Oticon Medical announced that it obtained 510(k) clearance from the FDA to market the Ponto Abutment Extension for bone anchored hearing. The new abutment extension connects to existing abutments so users can upgrade their bone anchored hearing solutions without changing abutments or undergoing further surgery.
Read More
Oticon Medical announced the appointment of Jared Schnackenberg as president of Oticon Medical US. He will provide overall leadership for the entire US organization to further develop Oticon Medical’s position in the bone anchored hearing solutions (BAHS) market and to prepare for the anticipated launch of Oticon Medical Cochlear Implants for the US market.
Read More
Oticon Medical has launched its Medical Streamer and ConnectLine App, enabling Ponto Plus sound processor users to control their bone anchored hearing solutions with just a tap of their iPhone, iPad, and iPod touch.
Read More
Oticon Medical, Somerset, NJ, has announced that it has obtained 510(k) clearance from the FDA to market Ponto Plus, the company’s newest family of bone anchored sound processors.
Read More
Oticon Medical recently presented the newest findings and technology in bone anchored implant systems at the Fourth International Symposium on Bone Conduction Hearing—Craniofacial Osseointegration in Newcastle upon Tyne, England.
Read More
Oticon Medical has launched a new Facebook page designed to help people with bone anchored hearing solutions and their families to share experiences and talk to other users in an open and friendly forum.
Read MoreOticon Medical has enhanced its website to focus on increasing the level of engagement of site visitors. The redesigned site includes practical and easily-accessed information and resources, including a clinic locator for bone anchored hearing practitioners and one-on-one communications with current Ponto users.
Read MoreSince its introduction 2 years ago, over 3,000 patients have received Oticon Medica1’s Ponto bone anchored hearing system in eight countries. A new retrospective white paper study of patients in the United States indicates that the Ponto system reflects strong patient acceptance with few failures.
Read MoreOticon Medical recently sponsored a Masterclass on bone anchored hearing aid (BAHA) systems at Stockholms Karolinska University Hospital. The Masterclass was initiated and organized by Professor Malou Hultcrantz of Karolinska Hospital’s Department of Otorhinolaryngology.
Read MoreOticon Medical announced that its Ponto Pro Power bone anchored hearing system has won an iF Product Design Award 2012. An international panel of judges recognized the Ponto Pro Power for its design quality, degree of innovation, functionality and ergonomics.
Read MoreGN ReSound announced that it has entered into a technology development and license agreement to supply 2.4 GHz wireless technology to Cochlear America’s implantable bone anchored hearing devices.
Read MoreGBI Research has released a new ENT device market report. The analysts forecast that cochlear implants and bone anchored hearing aid (BAHA) implants will be the fastest growing segments through 2017.
Read MoreOticon Medical has received Food and Drug Administration (FDA) 510(k) clearance for its Ponto Pro Power, the most powerful fully digital and programmable bone anchored power processor, according to the company.
Read MoreOticon Medical has received Food and Drug Administration (FDA) 510(k) clearance for its Ponto Pro Power, the most powerful fully digital and programmable bone anchored power processor, according to the company.
Read MoreCochlear Americas is conducting a free hearing heath fair this Saturday, May 14 in Charlotte, NC, and another on June 4 in Raleigh. The fair is designed for those with hearing loss who may be struggling with hearing aids and may benefit from cochlear implant and bone anchored devices.
Read More